S&P 500   4,307.18 (-0.30%)
DOW   33,838.38 (-0.37%)
QQQ   356.31 (-0.45%)
AAPL   174.41 (-0.22%)
MSFT   316.39 (-0.20%)
META   296.91 (-0.73%)
GOOGL   129.39 (-0.66%)
AMZN   129.12 (+0.00%)
TSLA   241.14 (-1.53%)
NVDA   412.30 (-0.91%)
NIO   8.17 (-4.22%)
BABA   85.95 (-2.66%)
AMD   94.91 (-1.34%)
T   15.12 (+0.00%)
F   12.36 (-0.56%)
MU   68.31 (-0.83%)
CGC   0.86 (+2.38%)
GE   110.65 (-0.54%)
DIS   81.63 (+0.47%)
AMC   7.50 (-1.57%)
PFE   32.64 (-0.15%)
PYPL   57.43 (-0.78%)
NFLX   381.38 (+0.41%)
S&P 500   4,307.18 (-0.30%)
DOW   33,838.38 (-0.37%)
QQQ   356.31 (-0.45%)
AAPL   174.41 (-0.22%)
MSFT   316.39 (-0.20%)
META   296.91 (-0.73%)
GOOGL   129.39 (-0.66%)
AMZN   129.12 (+0.00%)
TSLA   241.14 (-1.53%)
NVDA   412.30 (-0.91%)
NIO   8.17 (-4.22%)
BABA   85.95 (-2.66%)
AMD   94.91 (-1.34%)
T   15.12 (+0.00%)
F   12.36 (-0.56%)
MU   68.31 (-0.83%)
CGC   0.86 (+2.38%)
GE   110.65 (-0.54%)
DIS   81.63 (+0.47%)
AMC   7.50 (-1.57%)
PFE   32.64 (-0.15%)
PYPL   57.43 (-0.78%)
NFLX   381.38 (+0.41%)
S&P 500   4,307.18 (-0.30%)
DOW   33,838.38 (-0.37%)
QQQ   356.31 (-0.45%)
AAPL   174.41 (-0.22%)
MSFT   316.39 (-0.20%)
META   296.91 (-0.73%)
GOOGL   129.39 (-0.66%)
AMZN   129.12 (+0.00%)
TSLA   241.14 (-1.53%)
NVDA   412.30 (-0.91%)
NIO   8.17 (-4.22%)
BABA   85.95 (-2.66%)
AMD   94.91 (-1.34%)
T   15.12 (+0.00%)
F   12.36 (-0.56%)
MU   68.31 (-0.83%)
CGC   0.86 (+2.38%)
GE   110.65 (-0.54%)
DIS   81.63 (+0.47%)
AMC   7.50 (-1.57%)
PFE   32.64 (-0.15%)
PYPL   57.43 (-0.78%)
NFLX   381.38 (+0.41%)
S&P 500   4,307.18 (-0.30%)
DOW   33,838.38 (-0.37%)
QQQ   356.31 (-0.45%)
AAPL   174.41 (-0.22%)
MSFT   316.39 (-0.20%)
META   296.91 (-0.73%)
GOOGL   129.39 (-0.66%)
AMZN   129.12 (+0.00%)
TSLA   241.14 (-1.53%)
NVDA   412.30 (-0.91%)
NIO   8.17 (-4.22%)
BABA   85.95 (-2.66%)
AMD   94.91 (-1.34%)
T   15.12 (+0.00%)
F   12.36 (-0.56%)
MU   68.31 (-0.83%)
CGC   0.86 (+2.38%)
GE   110.65 (-0.54%)
DIS   81.63 (+0.47%)
AMC   7.50 (-1.57%)
PFE   32.64 (-0.15%)
PYPL   57.43 (-0.78%)
NFLX   381.38 (+0.41%)
NASDAQ:VALN

Valneva (VALN) News Today

$12.55
-0.22 (-1.72%)
(As of 09:30 AM ET)
Compare
Today's Range
$12.55
▼
$12.55
50-Day Range
$12.52
▼
$15.63
52-Week Range
$9.07
▼
$17.05
Volume
1,799 shs
Average Volume
7,309 shs
Market Capitalization
$871.72 million
P/E Ratio
89.64
Dividend Yield
N/A
Price Target
$22.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
msn.com logoValneva receives JE vaccine supply contract from US DoD
msn.com - September 25 at 8:35 AM
msn.com logoValneva gets new $32M supply contract for the U.S. government
msn.com - September 25 at 3:35 AM
finance.yahoo.com logoValneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32 Million
finance.yahoo.com - September 25 at 3:35 AM
msn.com logoU.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
msn.com - September 21 at 1:20 PM
markets.businessinsider.com logoValneva Reports Half Year 2023 Financial Results and Provides Corporate Updates
markets.businessinsider.com - September 21 at 8:20 AM
marketwatch.com logoValneva Loss Narrows on Reduced Costs
marketwatch.com - September 21 at 8:20 AM
msn.com logoValneva's half-year loss narrows on strong travel vaccine demand
msn.com - September 21 at 8:20 AM
finance.yahoo.com logoValneva Reports Half Year 2023 Financial Results and Provides Corporate Updates
finance.yahoo.com - September 21 at 8:20 AM
msn.com logoPfizer Lyme Disease Vaccine Shows Promise
msn.com - September 8 at 5:49 AM
markets.businessinsider.com logoAnalyst Ratings for Valneva
markets.businessinsider.com - September 7 at 5:09 PM
markets.businessinsider.com logoValneva Reports Positive Pediatric & Adolescent Phase 2 Booster Results For Lyme Disease Vaccine
markets.businessinsider.com - September 7 at 4:41 AM
finance.yahoo.com logoVALNEVA Declaration of shares and voting rights: August 31, 2023
finance.yahoo.com - September 6 at 3:02 AM
finance.yahoo.com logoValneva to Participate in Investor Conferences in the United States and Europe in September 2023
finance.yahoo.com - August 31 at 7:22 PM
msn.com logoHealth Canada accepts Valneva’s chikungunya vaccine filing for review
msn.com - August 29 at 11:17 PM
markets.businessinsider.com logoCanada Accepts Valneva's Chikungunya Vaccine License Application For Review
markets.businessinsider.com - August 29 at 7:40 AM
tmcnet.com logoHealth Canada Accepts Valneva's Chikungunya Vaccine License Application for Review
tmcnet.com - August 29 at 2:40 AM
finance.yahoo.com logoHealth Canada Accepts Valneva’s Chikungunya Vaccine License Application for Review
finance.yahoo.com - August 29 at 2:40 AM
finanznachrichten.de logoVALNEVA: Valneva Reports Positive Initial Phase 3 Safety Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate
finanznachrichten.de - August 28 at 6:38 AM
markets.businessinsider.com logoValneva Reports Positive Safety Data In Adolescents For Chikungunya Vaccine Candidate
markets.businessinsider.com - August 28 at 6:38 AM
marketwatch.com logoValneva Gets Positive Data in Chikungunya Vaccine Trial
marketwatch.com - August 28 at 6:38 AM
msn.com logoValneva reports data from chikungunya vaccine trial in adolescents
msn.com - August 28 at 6:38 AM
finance.yahoo.com logoValneva Reports Positive Initial Phase 3 Safety Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate
finance.yahoo.com - August 28 at 6:38 AM
benzinga.com logoNorthX Biologics Welcomes Dr Janet Hoogstraate as New CEO Following Merger with Valneva Clinical Trials Manufacturing Unit
benzinga.com - August 23 at 5:26 AM
marketwatch.com logoValneva to Get Up to $100 Mln in Funding for Research, Chikungunya Vaccine
marketwatch.com - August 17 at 6:48 AM
finance.yahoo.com logoValneva Announces Extension of Existing Loan Agreement
finance.yahoo.com - August 17 at 1:47 AM
msn.com logoValneva pushes FDA approval date for chikungunya vaccine
msn.com - August 15 at 6:09 PM
seekingalpha.com logoValneva falls as FDA extends review of chikungunya vaccine
seekingalpha.com - August 14 at 3:42 PM
marketwatch.com logoValneva Says FDA Has Delayed Chikungunya Vaccine Review Date
marketwatch.com - August 14 at 4:48 AM
markets.businessinsider.com logoFDA Extends PDUFA Date For Valneva's Chikungunya Virus Vaccine Candidate
markets.businessinsider.com - August 14 at 4:48 AM
marketwatch.com logoValneva Shares Slump After FDA Postpones Chikungunya Vaccine Review Date
marketwatch.com - August 14 at 4:48 AM
finance.yahoo.com logoValneva Announces PDUFA Date Extension for Chikungunya Virus Vaccine Candidate
finance.yahoo.com - August 14 at 4:48 AM
msn.com logoBella Hadid opens up about her journey with Lyme disease
msn.com - August 6 at 4:08 PM
finance.yahoo.com logoVALNEVA Declaration of shares and voting rights - July 31, 2023
finance.yahoo.com - August 3 at 8:14 AM
msn.com logoValneva SE (INRLF) Price Target Increased by 8.92% to 11.20
msn.com - August 2 at 8:15 PM
finance.yahoo.com logoVBI Vaccines Announces PreHevbri® is Now Available in the Netherlands and Belgium for the Prevention of Hepatitis B in Adults
finance.yahoo.com - July 19 at 9:28 AM
seekingalpha.com logoValneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Race
seekingalpha.com - July 18 at 4:17 AM
msn.com logoNJ Lyme disease cases rising. Could this vaccine kill it for good?
msn.com - July 7 at 8:58 AM
msn.com logoWould you volunteer your kid to test a Lyme disease vaccine? Here's why some parents will
msn.com - July 6 at 9:16 AM
finance.yahoo.com logoVALNEVA - Declaration of shares and voting rights: June 30, 2023
finance.yahoo.com - July 5 at 9:02 AM
technews.tmcnet.com logoNorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva
technews.tmcnet.com - July 3 at 8:58 AM
news.yahoo.com logoA woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yet
news.yahoo.com - June 27 at 8:03 PM
markets.businessinsider.com logoAccor Share Price: This French Stock Received an Upgraded Rating
markets.businessinsider.com - June 25 at 7:58 AM
uk.news.yahoo.com logoWorst of Westminster: Labour Lords U-turn and interest rates hike
uk.news.yahoo.com - June 23 at 12:53 PM
marketwatch.com logoValneva Announces Successful Outcome of its AGM and the Appointment of Pfizer's Former Vaccine R&D Head to its Supervisory Board
marketwatch.com - June 22 at 3:48 PM
finanznachrichten.de logoVALNEVA: Valneva Supervisory Board Recommends Transition from a Two-Tier Governance Model to a Board of Directors
finanznachrichten.de - June 22 at 9:38 AM
finanznachrichten.de logoVALNEVA: Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer's Former Vaccine R&D Head to its Supervisory Board
finanznachrichten.de - June 22 at 9:38 AM
finance.yahoo.com logoValneva Supervisory Board Recommends Transition from a Two-Tier Governance Model to a Board of Directors
finance.yahoo.com - June 22 at 9:38 AM
thetimes.co.uk logoCancelled Covid-19 vaccine made in Scotland cost taxpayers £358m
thetimes.co.uk - June 21 at 11:20 PM
msn.com logoAxed Livingston Covid vaccine contract cost taxpayers £358million
msn.com - June 21 at 1:19 PM
finance.yahoo.com logoStrength Seen in Valneva SE Sponsored ADR (VALN): Can Its 15.8% Jump Turn into More Strength?
finance.yahoo.com - June 21 at 1:19 PM
Get Valneva News Delivered to You Automatically

Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter.



VALN Media Mentions By Week

VALN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VALN
News Sentiment
▼
-0.25

0.51
▲
Average
Medical
News Sentiment

VALN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VALN Articles
This Week
▼
10

2
▲
VALN Articles
Average Week

Get Valneva News Delivered to You Automatically

Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:VALN) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -